Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | VDR | P11473 | 1/20 | 0.40 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.38 |
| ▸ | GABRD | O14764 | 2/20 | 0.38 |
| ▸ | G6PD | P11413 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.38 |
| ▸ | GABRE | P78334 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6444178 | 1.00 | CYP2C9 (0.40) | CYP2C9MEN1KMT2AHIF1AVDR | |
| SCHEMBL27663534 | 0.89 | CYP19A1 (0.45) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6442680 | 0.89 | CYP3A4 (0.40) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6446950 | 0.89 | CYP3A4 (0.40) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6439906 | 0.89 | CYP3A4 (0.40) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6442484 | 0.88 | MEN1 (0.39) | CYP2C9MEN1KMT2AHIF1AVDR | |
| SCHEMBL6442230 | 0.88 | MEN1 (0.39) | CYP2C9MEN1KMT2AHIF1AVDR | |
| SCHEMBL6444372 | 0.87 | KMT2A (0.39) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6445468 | 0.87 | KMT2A (0.39) | CYP2C9MEN1KMT2ACYP3A4GABRP | |
| SCHEMBL6444908 | 0.86 | MEN1 (0.40) | MEN1KMT2ACYP3A4G6PDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050159366-A1 | Pharmaceutical compositions and treatment methods - 8 | BIOVIE INC. | 2005-07-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159366-A1 | Pharmaceutical compositions and treatment methods - 8 | HSD17B7, NR5A1, HSD3B1 | CYP2C9 468/4885MEN1 2269/4885KMT2A 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.